Prague Med. Rep. 2023, 124, 344-358
https://doi.org/10.14712/23362936.2023.27
Potential Mechanism of Platelet-rich Plasma Treatment on Testicular Problems Related to Diabetes Mellitus
References
1. 1989) Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol. Reprod. 41(1), 183–197.
< , R. J., Clarkson, J. S., Fishel, S. (https://doi.org/10.1095/biolreprod41.1.183>
2. 2018) A review of platelet-rich plasma: History, biology, mechanism of action, and classification. Skin Appendage Disord. 4(1), 18–24.
< , R., Grimalt, R. (https://doi.org/10.1159/000477353>
3. American Diabetes Association (2009) Standards of medical care in diabetes – 2009. Diabetes Care 32, S13–S61 (Suppl. 1).
4. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37, S81–S90 (Suppl. 1).
5. 2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat. Rev. Rheumatol. 9(12), 721–730.
< , I., Maffulli, N. (https://doi.org/10.1038/nrrheum.2013.141>
6. 2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22(10), 1276–1312.
< , J., Gallini, R., Betsholtz, C. (https://doi.org/10.1101/gad.1653708>
7. 2019) Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: Review of the literature. J. Endocr. Soc. 3(10), 1799–1818.
< , K., Uy, E. M. (https://doi.org/10.1210/js.2019-00160>
8. 2020) In vitro effect of autologous platelet-rich plasma on H2O2-induced oxidative stress in human spermatozoa. Andrology 8(1), 191–200.
< , R., Ibrahim, J. N., Moussa, M., Mourad, A., Azoury, J., Azoury, J., Alaaeddine, N. (https://doi.org/10.1111/andr.12648>
9. 2021) Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci. Rep. 11(1), 3971.
< , H., Leon, J., Pont, J. L., Wilson, D. A., Bansal, A., Agarwal, D., Preoteasa, I. (https://doi.org/10.1038/s41598-021-83025-2>
10. 2008) Growth factors and cytokines in wound healing. Wound Repair Regen. 16(5), 585–601.
< , S., Stojadinovic, O., Golinko, M. S., Brem, H., Tomic-Canic, M. (https://doi.org/10.1111/j.1524-475X.2008.00410.x>
11. 2009) Epidermal growth factor in clinical practice – A review of its biological actions, clinical indications and safety implications. Int. Wound J. 6(5), 331–346.
< , J., Gavilondo-Cowley, J., López-Saura, P., González-López, T., Castro-Santana, M. D., López-Mola, E., Guillén-Nieto, G., Herrera-Martinez, L. (https://doi.org/10.1111/j.1742-481X.2009.00622.x>
12. 2012) Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy 28(3), 429–439.
< , S. G., Cole, B. J., Sundman, E. A., Karas, V., Fortier, L. A. (https://doi.org/10.1016/j.arthro.2011.10.018>
13. 2006) The NF-κB regulatory network. Cardiovasc. Toxicol. 6(2), 111–130.
< , A. R. (https://doi.org/10.1385/CT:6:2:111>
14. 2012) VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo. Endocrinology 153(2), 887–900.
< , K. C., de Avila, J. M., Cupp, A. S., McLean, D. J. (https://doi.org/10.1210/en.2011-1323>
15. 2019) Platelet-rich products and their application to osteoarthritis. J. Equine Vet. Sci. 86, 102820.
Garbin, L., Olver, C. (
16. 2019) Potential effect of advanced glycation end products (AGEs) on spermatogenesis and sperm quality in rodents. Food Funct. 10(6), 3324–3333.
< , M. C., Lin, J. A., Lin, H. T., Chen, S. Y., Yen, G. C. (https://doi.org/10.1039/C9FO00240E>
17. 2020) Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 16(7), 377–390.
< , J. B., Florez, J. C. (https://doi.org/10.1038/s41581-020-0278-5>
18. 2018) Diabetes mellitus and infertility: Different pathophysiological effects in type 1 and type 2 on sperm function. Front. Endocrinol. (Lausanne) 9, 268.
< , R. A., La Vignera, S., Mongioì, L. M., Alamo, A., Calogero, A. E. (https://doi.org/10.3389/fendo.2018.00268>
19. 2011) Determinants of platelet count in humans. Haematologica 96(1), 10–13.
< , M. E. (https://doi.org/10.3324/haematol.2010.035287>
20. 2014) Platelet-rich preparations to improve healing. Part I: Workable options for every size practice. J. Oral Implantol. 40(4), 500–510.
< , V. L., Abukabda, A. B., Radio, N. M., Witt-Enderby, P. A., Clafshenkel, W. P., Cairone, J. V., Rutkowski, J. L. (https://doi.org/10.1563/AAID-JOI-D-12-00104>
21. 2018) Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice. Clin. Exp. Reprod. Med. 45(2), 67–74.
< , A. S., Salem, H. A. (https://doi.org/10.5653/cerm.2018.45.2.67>
22. 2019) The use of platelet-rich plasma (PRP) to improve structural impairment of rat testis induced by busulfan. Platelets 30(4), 513–520.
< , F., Sotoude, N., Bordbar, H., Panjeshahin, M. R., Karbalay-Doust, S. (https://doi.org/10.1080/09537104.2018.1478400>
23. 2014) PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev. 25(3), 273–283.
< , J. B., Essaghir, A. (https://doi.org/10.1016/j.cytogfr.2014.03.003>
24. 2012) Platelet-rich plasma therapy – Future or trend? Arthritis Res. Ther. 14(4), 219.
< , R. S., Schwarz, E. M., Maloney, M. D. (https://doi.org/10.1186/ar3914>
25. 2014) Principles and methods of preparation of platelet-rich plasma: A review and author’s perspective. J. Cutan. Aesthet. Surg. 7(4), 189–197.
< , R., Sukesh, M. (https://doi.org/10.4103/0974-2077.150734>
26. 2009) Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to Leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 27(3), 158–167.
< Ehrenfest, D. M., Rasmusson, L., Albrektsson, T. (https://doi.org/10.1016/j.tibtech.2008.11.009>
27. 2004) The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 15(4), 197–204.
< , L., Li, H., Eriksson, U. (https://doi.org/10.1016/j.cytogfr.2004.03.007>
28. 2020) Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21(17), 6275.
< , U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., Martín, C. (https://doi.org/10.3390/ijms21176275>
29. 2006) Introduction to NF-κB: Players, pathways, perspectives. Oncogene 25(51), 6680–6684.
< , T. D. (https://doi.org/10.1038/sj.onc.1209954>
30. 2008) Wound repair and regeneration. Nature 453(7193), 314–321.
< , G. C., Werner, S., Barrandon, Y., Longaker, M. T. (https://doi.org/10.1038/nature07039>
31. 2019) Therapeutic medications against diabetes: What we have and what we expect. Adv. Drug Deliv. Rev. 139, 3–15.
< , C., Jia, W. (https://doi.org/10.1016/j.addr.2018.11.008>
32. IDF (2021) Diabetes around the world in 2021. Available at: https://diabetesatlas.org/
33. 2004) The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 104(12), 3603–3610.
< , G., Tirschmann, K., Lubenow, L. E., Nieuwenhuis, H. K., Akkerman, J. W., Greinacher, A., Kroemer, H. K. (https://doi.org/10.1182/blood-2003-12-4330>
34. 2011) Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men. Diabetes Res. Clin. Pract. 91(1), 61–66.
< , J., Goodarzi, M. T., Tavilani, H., Khodadadi, I., Amiri, I. (https://doi.org/10.1016/j.diabres.2010.09.024>
35. KEMENKES (2018) Diabetes: Penderita di Indonesia bisa mencapai 30 juta orang pada tahun 2030. Available at: https://p2ptm.kemkes.go.id/tag/diabetes-penderita-di-indonesia-bisa-mencapai-30-juta-orang-pada-tahun-2030
36. 2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89–116.
< , T. W., Wakabayashi, N., Biswal, S. (https://doi.org/10.1146/annurev.pharmtox.46.120604.141046>
37. 2022) Advanced glycation end products and diabetes mellitus: Mechanisms and perspectives. Biomolecules 12(4), 542.
< , M., Petroianu, G., Adem, A. (https://doi.org/10.3390/biom12040542>
38. 2016) Is platelet-rich plasma a future therapy in pain management? Med. Clin. North Am. 100(1), 199–217.
< , N. N., Candido, K. D., Desai, R., Kaye, A. D. (https://doi.org/10.1016/j.mcna.2015.08.014>
39. 2021) Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomed. Pharmacother. 133, 110975.
< , M., Xie, K., Lv, M., Li, J., Yao, J., Yan, K., Wu, X., Xu, Y., Ye, D. (https://doi.org/10.1016/j.biopha.2020.110975>
40. 2011) Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): Implications for preeclampsia. J. Biol. Chem. 286, 42863–42872.
< , N., Fragoulis, A., Rosen, C., Pecks, U., Rath, W., Pufe, T., Wruck, C. (https://doi.org/10.1074/jbc.M111.286880>
41. 2016) Serum and seminal plasma insulin-like growth factor-1 in male infertility. Clin. Exp. Reprod. Med. 43(2), 97–101.
< , H. S., Park, Y. S., Lee, J. S., Seo, J. T. (https://doi.org/10.5653/cerm.2016.43.2.97>
42. 2005) DNA damage to spermatozoa has impacts on fertilization and pregnancy. Cell Tissue Res. 322(1), 33–41.
< , S. E., Aitken, R. J. (https://doi.org/10.1007/s00441-005-1097-5>
43. 2018) Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway. Oncotarget 9(4), 5321–5336.
< , L., Qiu, H., Cai, B., Chen, N., Lu, X., Zheng, S., Ye, X., Li, Y. (https://doi.org/10.18632/oncotarget.23915>
44. 2009) Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil. Steril. 91(3), 805–811.
< , R., Sharma, R., Sharma, D., Sabanegh, E., Agarwal, A. (https://doi.org/10.1016/j.fertnstert.2008.01.022>
45. 2019) Growth factor quantification of platelet-rich plasma in burn patients compared to matched healthy volunteers. Int. J. Mol. Sci. 20(2), 288.
< , R. E., Gardien, K. L. M., Vlig, M., Breederveld, R. S., Middelkoop, E. (https://doi.org/10.3390/ijms20020288>
46. 2017) Hyperglycemia is associated with reduced testicular function and activin dysregulation in the Ins2(Akita+/–) mouse model of type 1 diabetes. Mol. Cell. Endocrinol. 446, 91–101.
< , C. C., Stute, D. C., Ludlow, H., Hammes, H. P., de Kretser, D. M., Hedger, M. P., Linn, T. (https://doi.org/10.1016/j.mce.2017.02.020>
47. 2015) Platelet-rich plasma (PRP): Methodological aspects and clinical applications. Platelets 26(2), 101–113.
< , L. F., Stessuk, T., Camargo, I. C., Sabeh Junior, N., dos Santos, L., Ribeiro-Paes, J. T. (https://doi.org/10.3109/09537104.2014.881991>
48. 2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J. Thromb. Haemost. 5(9), 1945–1955.
< , D. M., Heijnen, H. F., Horne, M. K., White, J. G., Gahl, W. A. (https://doi.org/10.1111/j.1538-7836.2007.02690.x>
49. 2019) Use of platelet-rich plasma to facilitate wound healing. Int. Wound J. 16(2), 343–353.
< , Y., Mirzakulova, U., Yui, R. (https://doi.org/10.1111/iwj.13034>
50. 2016) Evaluation of enzymatic and non-enzymatic antioxidants in seminal plasma of men with genitourinary infections, varicocele and idiopathic infertility. Andrology 4(3), 456–464.
< , L., Cerretani, D., Collodel, G., Menchiari, A., Moltoni, L., Fiaschi, A. I., Moretti, E. (https://doi.org/10.1111/andr.12181>
51. 2021) Use of PRP, PRF and CGF in periodontal regeneration and facial rejuvenation – A narrative review. Biology (Basel) 10(4), 317.
, E., Assaf, H. D., Peleg, O., Shacham, M., Cerroni, L., Mangani, L. (
52. 2010) Knockout of the transcription factor NRF2 disrupts spermatogenesis in an age-dependent manner. Free Radic. Biol. Med. 49(9), 1368–1379.
< , B. N., Lawson, G., Chan, J. Y., Banuelos, J., Cortés, M. M., Hoang, Y. D., Ortiz, L., Rau, B. A., Luderer, U. (https://doi.org/10.1016/j.freeradbiomed.2010.07.019>
53. 2002) Detection of oxidative stress in seminal plasma and fractionated sperm from subfertile male patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 105(2), 155–160.
< , H., Kimura, T., Nakajima, A., Shimoya, K., Takemura, M., Hashimoto, K., Isaka, S., Azuma, C., Koyama, M., Murata, Y. (https://doi.org/10.1016/S0301-2115(02)00194-X>
54. 2010) Effects of a highly concentrated platelet-rich plasma on the bone repair using non-critical defects in the calvaria of rabbits. Acta Cir. Bras. 25(1), 28–33.
< Filho, M. A., Nassif, P. A., Malafaia, O., Ribas Filho, J. M., Ribas, C. A., Camacho, A. C., Stieven Filho, E., Giovanini, A. F. (https://doi.org/10.1590/S0102-86502010000100008>
55. 2019) A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following platelet-rich plasma treatment. Cell Transplant. 28(9–10), 1333–1340.
< , K., Simopoulou, M., Pantou, A., Rapani, A., Tsioulou, P., Nitsos, N., Syrkos, S., Pappas, A., Koutsilieris, M., Sfakianoudis, K. (https://doi.org/10.1177/0963689719859539>
56. 2016) Platelet rich plasma: A short overview of certain bioactive components. Open Med. (Wars.) 11(1), 242–247.
< , V., Ciric, M., Jovanovic, V., Stojanovic, P. (https://doi.org/10.1515/med-2016-0048>
57. 2003) Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clin. Diabetes 21(4), 186–187.
< , M., Uribarri, J., Vlassara, H. (https://doi.org/10.2337/diaclin.21.4.186>
58. 2017) Mechanism action of platelets and crucial blood coagulation pathways in hemostasis. Int. J. Hematol. Oncol. Stem Cell Res. 11(4), 319–327.
, M. H., Halim, A. S., Mat Saad, A. Z. (
59. 2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8(1), 49–62.
< , N. D. (https://doi.org/10.1038/nrm2083>
60. 2014) Effect of superoxide dismutase on semen parameters and antioxidant enzyme activities of liquid stored (5°C) Mithun (Bos frontalis) semen. Journal of Animals 2014, 821954.
, P. (
61. 2019) Effect of gamma-mangostin on testosterone levels in Leydig cell culture of Sprague-Dawley rat induced by advanced glycation end products: A preliminary study. BMC Proc. 13, 12 (Suppl. 11).
< , D. M., Fauzi, A. R., Rustamaji (https://doi.org/10.1186/s12919-019-0173-x>
62. 2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843.
< , P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R. (https://doi.org/10.1016/j.diabres.2019.107843>
63. 2018) Renoprotective effect of platelet-rich plasma on cisplatin-induced nephrotoxicity in rats. Oxid. Med. Cell. Longev. 2018, 9658230.
< , N., Helmi, N., Assaf, N. (https://doi.org/10.1155/2018/9658230>
64. 2020) The potential protective and therapeutic effects of platelet-rich plasma on ischemia/reperfusion injury following experimental torsion/detorsion of testis in the Albino rat model. Life Sci. 256, 117982.
< , A., El-Adl, M., Rezk, S., Marghani, B., Eldomany, W., Eldesoky, A., Elmetwally, M. A. (https://doi.org/10.1016/j.lfs.2020.117982>
65. 2018) Treatment of muscle injuries with platelet-rich plasma: A review of the literature. Curr. Rev. Musculoskelet. Med. 11(4), 635–642.
< , K., Villarreal, A., Gottschalk, A., Tokish, J. M., Choate, W. S. (https://doi.org/10.1007/s12178-018-9526-8>
66. 2007) Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat. Int. J. Androl. 30(6), 508–518.
< , B. (https://doi.org/10.1111/j.1365-2605.2007.00748.x>
67. 2007) Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: Its progression and genotoxic consequences. Reprod. Toxicol. 23(4), 578–587.
< , B., Muralidhara (https://doi.org/10.1016/j.reprotox.2007.02.001>
68. 2017) Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway. Theranostics 7(3), 733–750.
< , S.-C., Yuan, T., Rui, B.-Y., Zhu, Z.-Z., Guo, S.-C., Zhang, C.-Q. (https://doi.org/10.7150/thno.17450>
69. 2005) Malondialdehyde levels in sperm and seminal plasma of asthenozoospermic and its relationship with semen parameters. Clin. Chim. Acta 356(1–2), 199–203.
< , H., Doosti, M., Saeidi, H. (https://doi.org/10.1016/j.cccn.2005.01.017>
70. 2022) The use of platelet-rich plasma in management of musculoskeletal pain: A narrative review. J. Yeungnam Med. Sci. 39(3), 206–215.
< , A. C. (https://doi.org/10.12701/jyms.2022.00290>
71. 2022) The role of platelet rich plasma in knee joint pain. Anaesthesia, Pain and Intensive Care 26(3), 405–409.
< , C., Hidayati, H. B., Yudiyanta, Pranowo, I., Puspamaniar, V. A. (https://doi.org/10.35975/apic.v26i3.1906>
72. 2014) Role of platelet-released growth factors in detoxification of reactive oxygen species in osteoblasts. Bone 65, 9–17.
< , M., Wruck, C.-J., Slowik, A., Kweider, N., Beckmann, R., Bayer, A., Houben, A., Brandenburg, L. O., Varoga, D., Sönmez, T. T., Stoffel, M., Jahr, H., Lippross, S., Pufe, T. (https://doi.org/10.1016/j.bone.2014.04.029>
73. 2005) Protective effect of vascular endothelial growth factor on histologic changes in testicular ischemia-reperfusion injury. Fertil. Steril. 84(2), 468–473.
< , A., Cayan, S., Bozlu, M., Yilmaz, N., Acar, D., Akbay, E. (https://doi.org/10.1016/j.fertnstert.2005.01.144>
74. 2021) Platelet-rich plasma: A comprehensive review of emerging applications in medical and aesthetic dermatology. J. Clin. Aesthet. Dermatol. 14(11), 44–57.
, C., Brahs, A., Dorton, D., Witfill, K. (
75. Williams, O., Sergent, S. R. (2022) Histology, Platelets. StatPearls [Internet].
76. 2011) Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 32(25), 5847–5854.
< , C. C., Chen, W. H., Zao, B., Lai, P. L., Lin, T. C., Lo, H. Y., Shieh, Y. H., Wu, C. H., Deng, W. P. (https://doi.org/10.1016/j.biomaterials.2011.05.002>
77. 2014) Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res. Ther. 16(1), 204.
< , X., Zhang, C., Tuan, R. S. (https://doi.org/10.1186/ar4493>
78. 2008) Advanced glycation end products (AGEs) and their receptor (RAGE) in health and disease. Curr, Pharm. Des. 14(10), 939.
< , S. (https://doi.org/10.2174/138161208784139756>
79. 2016a) Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. Sci. Rep. 6, 22386.
< , J., Dong, X., Hu, X., Long, Z., Wang, L., Liu, Q., Sun, B., Wang, Q., Wu, Q., Li, L. (https://doi.org/10.1038/srep22386>
80. 2016b) Advanced glycation end products inhibit testosterone secretion by rat Leydig cells by inducing oxidative stress and endoplasmic reticulum stress. Int. J. Mol. Med. 38(2), 659–665.
< , Y. T., Qi, Y. W., Hu, C. Y., Chen, S. H., Liu, Y. (https://doi.org/10.3892/ijmm.2016.2645>
81. 2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88–98.
< , Y., Ley, S. H., Hu, F. B. (https://doi.org/10.1038/nrendo.2017.151>